Drugs / Levodopa Benserazide
last change Dec 2015 re-read 3 minutes ago

Levodopa Benserazide

Developed for
Parkinson disease
Investigated by
Agenzia Italiana del Farmaco · IRCCS San Raffaele Roma

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02741947 Apr 2014 → Dec 2015 Parkinson disease IRCCS San Raffaele Roma Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Levodopa Benserazide ClinicalTrials.gov intervention name — accepted as the source's own label NCT02741947 ↗
Route Oral “The drugs was administered orally.” NCT02741947 ↗